Cell and Gene Outsourcing

  1. Optimizing Viability And Standardization For Clinical Excellence 10/2/2024

    Explore how IntegriCell™ delivers high-quality, manufacture-ready cryopreserved leukopaks, vital for consistent and reliable cell therapy production.

  2. Delivering Therapies To Patients At Scale And At Speed 10/13/2021

    Resilience is addressing a defining challenge: Biopharmaceutical manufacturing has not kept pace with scientific advancement, preventing new discoveries from reaching patients at speed or scale.

  3. Quality Agreements: Defining Governance In CDMO Partnerships 5/15/2024

    Quality agreements serve a critical role within a CDMO-Sponsor partnership. Review the importance of aligning objectives, quality standards, and compliance frameworks to establish a robust foundation.

  4. Optimization-By-Design — A Critical Factor In Viral Vector Scale Up 12/14/2023

    Learn how leveraging the expertise and capabilities of an experienced partner is a key factor in optimizing AAV processes using Design of Experiment (DoE), thereby reducing variability and risk.

  5. A Robust And Scalable Suspension Platform For AAV Manufacturing

    Review the demands for AAV manufacturing using a suspension process and the DOE-based strategy used to achieve a scalable process both in terms production and quality of AAV purified.

  6. Cryopreservation Best Practices For Cell & Gene Therapy Source Material 2/26/2024

    Industry experts share their experiences, including why and how cellular source materials are cryopreserved and why experience across cell types and methods matters.